已收盤 08-07 16:00:00 美东时间
+3.760
+1.17%
Big Pharma moved back into the spotlight last week following a Financial Times report that Bristol Myers Squibb (BMY) was in merger talks with AstraZeneca (AZN), a development that was later denied by...
今天 03:28
今日重点评级关注:巴克莱:维持Snap"超配"评级,目标价从15美元升至16美元;Canaccord Genuity:维持阿梅雷斯克"买入"评级,目标价从59美元升至62美元
08-05 11:45
Citigroup analyst Yigal Nochomovitz maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the price target from $378 to $386.
08-04 23:28
华盛资讯8月4日讯,Krystal Biotech公布2026财年Q2业绩,公司Q2营收1.19亿美元,同比增长24.0%,归母净利润0.55亿美元,同比增长44.7%。
08-04 04:05
华盛资讯8月4日讯,Krystal Biotech公布2026财年Q2业绩,公司Q2营收1.19亿美元,同比增长24.1%,归母净利润0.55亿美元,同比增长42.9%。
08-04 02:17
谢里特国际对Kyma Capital关于董事会的征召作出回应;公司董事会认定该征召根据《加拿大商业公司法》已失效;公司已宣布年度股东大会将于12月15日举行...
08-03 20:27
Krystal Biotech shares are trading lower after the company announced mixed Q2 financial results.
08-03 19:58
Krystal Biotech (NASDAQ:KRYS) reported quarterly earnings of $1.79 per share which beat the analyst consensus estimate of $1.66 by 7.83 percent. This is a 38.76 percent increase over earnings of $1.29 per share from the same period last year. The company reported quarterly sales of $119.222 million ...
08-03 19:00
S&P Global (SPGI) is scheduled to announce Q2 earnings results on Tuesday, July 28th, before market open. The consensus EPS Estimate is $5.02 (+13.3% Y/Y) and the consensus Revenue Estimate is $4.12B ...
07-28 00:44